ResMed (RMD) Dividend Yield & History

RMD$239.53+0.64 +0.27%
Medical - Instruments & SuppliesLarge CapHigh Quality
Compare
Market cap$33.69BEnterprise value$33.56BRevenue (TTM)$5.73BMarket positionTop 25%

Score

61
Neutral
Value
48
Quality
86
Growth
48
$239.53Price
$33.69BMarket cap
21.15P/E
19.48Forward P/E
1.03%Dividend yield

Yield is based on dividends paid in the past 12 months. 2026 isn't counted in streaks until the year ends.

1.03% is the yield on ResMed Inc. at $239.53, from $2.46 a share over the past year.

ResMed raised the yearly dividend in every year from 2012 through 2025.

From $0.60 to $0.66 on 19 August 2026: the ResMed quarterly dividend, up 10%.

39% of ResMed earnings funded the dividend last year.

A ResMed dividend is paid quarterly.

The next ex-dividend date for ResMed hasn't been announced yet.

ResMed grew its dividend 7.7% a year across five years.

Our records cover 58 payments from 2012 to 2026.

At today's yield, $10,000 invested would receive about $103 a year in dividends before tax, if payments stay the same. Dividends can be cut.

Learn: How to read a dividend

Full RMD quote · Forecast · Academy

Questions

When did RMD last raise the dividend?

19 August 2026: $0.60 then $0.66.

How often does RMD pay a dividend?

RMD paid a dividend 4 times in the past year.

How many years has RMD raised the dividend?

Higher every year, 2012 through 2025 ($2.26 in 2025).

What is the RMD dividend yield?

Yield on ResMed: 1.03%.

ResMed (RMD) Dividend Yield & History

RMD price $239.53 +0.64 +0.27%

Ticker
RMD
Price
$239.53
Change
+0.64 +0.27%
Market cap
$33.69B
P/E
21.15
Forward P/E
19.48
Dividend yield
1.04%
Beta
0.76
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Stocklytics score
61
Value
48
Quality
86
Growth
48

Stocklytics score rationale: value 48, quality 86, growth 48.

AI Score 75. ResMed Inc. has a solid market capitalization of approximately $32.34 billion and a strong net profit margin of 27.79%, indicating effective cost management

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener